HanAll F&B plans rice pasta and naengmyeon expansion after filing patent for improved noodle manufacturing
EPACK Prefab Technologies expands Rajasthan manufacturing capacity with Rs 1,376cr order book, but margins remain under pressure
Read More Pharma Industry News Sanofi Consumer Healthcare India Q1 FY2025 results: PAT climbs 12.9% post-demerger, stock holds premium valuation Sanofi Consumer Healthcare India Q1 FY2025 PAT rose 12.9% to ₹500 million. Read stock analysis, investor sentiment, and growth outlook post demerger. byPallavi MadhirajuMay 4, 2025